Mike Dragunow is a Professor of pharmacology at the University of Auckland, Auckland, New Zealand. He obtained his Ph.D. degree from the University of Otago in Dunedin, New Zealand and undertook postdoctoral training in Canada and Switzerland. Mike is a Molecular Pharmacologist and Neuroscientist, and his research focuses on the molecular mechanisms of neurodegeneration and brain repair and on developing novel treatments for human brain diseases using adult human brain material, tissue microarray, cell culture models (cell lines and adult human brain cell cultures), molecular pharmacology, and high-content analysis and screening. These combined research tools are being used to understand the causes of human neurodegeneration and to test and develop new treatment strategies. His contributions to research have been recognized by the New Zealand Association of Scientists Research Award (1996); Dragunow was appointed as a Personal Chair in pharmacology at the University of Auckland (1999), elected to a Fellowship of the Royal Society of New Zealand (2000), and offered the membership of a number of editorial boards. Moreover, he served as a Consultant to Biotech, and by listing, Dragunow is considered a highly cited author (since 2002) according to the ISI Web of Knowledge, in their neuroscience category, with over 13,000 citations and an H-index of 63.
Biography Updated on 7 February 2011